Relicaps ADVANCE rectal capsules 206mg №10×1

Name:
Relicaps ADVANCE caps.rect.206mg in box.cell.pack No. 10×1
Description:
Capsules are soft gelatin drop-shaped, with a seam, elastic, opaque, from white to light yellow in color. The main active ingredient Benzocaine Release form Capsules Dosage 206 mg. Indications for use Relicaps advance is used as a symptomatic agent in the complex therapy of hemorrhoids and anal fissures. Dosage and administration Relicaps advance is injected into the rectum, one rectal capsule up to 4 times a day (in the morning, at night and after each bowel movement). The drug is used after hygiene procedures. The duration of the course of treatment is determined by the doctor, taking into account the characteristics of the disease, the tolerability of the drug and the effect achieved. Use during pregnancy and lactation The drug is not recommended for use by women during pregnancy and lactation. Precautions In patients with arterial hypertension, cardiac arrhythmias, hyperthyroidism, urination disorders (for example, in the case of prostatic hyperplasia), the drug can be used only after consulting a doctor. It is necessary to use the smallest dose of the drug sufficient to achieve the effect. In case of heavy bloody discharge from the anus or the absence of a therapeutic effect when using the drug, you should consult a doctor. When using drugs containing benzocaine, there have been reports of the development of methemoglobinemia (cyanosis of the skin, lips and nail plates, headache, dizziness, respiratory failure, general weakness, tachycardia), which can be fatal and requires emergency medical care. The risk of complications in the development of methemoglobinemia is higher in young children, the elderly, patients with hereditary disorders (deficiency of the enzymes glucose-6-phosphodiesterase, pyruvate kinase, NADH-methemoglobin reductase (diaphorase 1), M-hemoglobinopathy), heart disease, respiratory diseases ways (bronchial asthma, bronchitis, emphysema) or in case of smoking. Interaction with other drugs The drug should not be used with the simultaneous use of MAO inhibitors, antidepressants and antihypertensive drugs. Contraindications hypersensitivity to the components of the drug, as well as to other amide-type anesthetics; thromboembolism (including previously transferred); granulocytopenia. Composition One capsule contains: benzocaine – 206 mg. Excipients: shark liver oil, polysorbate 80, alpha-tocopherol, glycerol monostearate, sunflower oil. The composition of the shell of the gelatin capsule: gelatin, glycerin, sodium benzoate, purified water, titanium dioxide E-171. Overdose hypersensitivity to the components of the drug, as well as to other amide-type anesthetics; thromboembolism (including previously transferred); granulocytopenia. Side effects The following adverse reactions are possible: contact dermatitis, skin allergic reactions (hyperemia, skin rash, itching), local reactions at the site of application of the drug. When using the drug, methemoglobinemia may develop (cyanosis of the skin, lips and nail plates, headache, dizziness, respiratory failure, general weakness, tachycardia). In the event of adverse reactions, including those not listed in the instructions for use, it is necessary to stop using the drug and consult a doctor. Storage conditions Store at a temperature not exceeding 25°C. Store in a place inaccessible to children. Buy Relicaps ADVANCE rectal capsules 206mg No. 10×1 Price for Relicaps ADVANCE rectal capsules 206mg No. 10×1